Chisato M Yamazaki

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Diffusion Weighted

Top Venues

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Summer Y Y Ha, Yasuaki Anami, Chisato M Yamazaki, Wei Xiong, Candice M Haase, Scott D Olson, Jangsoon Lee, Naoto Tada Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates. Molecular cancer therapeutics 21 (9) (2022)
Yasuaki Anami, Wei Xiong, Aiko Yamaguchi, Chisato M Yamazaki, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Homogeneous antibody-angiopep 2 conjugates for effective brain targeting. RSC advances 12 (6) (2022)
Chisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami, Wei Xiong, Yoshihiro Otani, Jangsoon Lee, Naoto Tada Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nature communications 12 (1) (2021)
Yasuaki Anami, Mi Deng, Xun Gui, Aiko Yamaguchi, Chisato M Yamazaki, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia. Molecular cancer therapeutics 19 (11) (2020)
Yasuaki Anami, Chisato M Yamazaki, Wei Xiong, Xun Gui, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice. Nature communications 9 (1) (2018)